Young J P, Coleman A, Lader M H
St Thomas's Hospital, London.
Br J Psychiatry. 1987 Sep;151:337-40. doi: 10.1192/bjp.151.3.337.
Fluoxetine, a selective serotonin uptake inhibitor (mean dose 73 mg each morning) was compared with amitriptyline (mean dose 122 mg at night) in a double-blind study of 64 depressed out-patients. Fifty patients completed the 6-week trial. The drugs did not differ with respect to psychiatrists' ratings, but amitriptyline was slightly superior with respect to patients' ratings. The amitriptyline-treated group had complaints of dry mouth and dizziness on standing; the fluoxetine-treated group of sleep disturbances, nausea, and headaches.
在一项针对64名门诊抑郁症患者的双盲研究中,将氟西汀(一种选择性5-羟色胺再摄取抑制剂,平均每日晨起剂量73毫克)与阿米替林(平均每日夜间剂量122毫克)进行了比较。50名患者完成了为期6周的试验。在精神科医生的评分方面,两种药物没有差异,但在患者的评分方面,阿米替林略占优势。接受阿米替林治疗的组出现口干和站立时头晕的症状;接受氟西汀治疗的组出现睡眠障碍、恶心和头痛的症状。